investigated neoantigen-specific T cells in combination with α-CTLA4 or α-PD1 in Lewis lung carcinoma and observed an expansion of neoantigen-specific CD8+ TIL after ICI therapy but no effect on tumor regression (57). The gene discussed is CD8A; the disease is neoplasm.